DK0640077T3 - Oxazolidiner indeholdende en substitueret diazingruppe samt deres anvendelse som antimikrobielle midler - Google Patents

Oxazolidiner indeholdende en substitueret diazingruppe samt deres anvendelse som antimikrobielle midler

Info

Publication number
DK0640077T3
DK0640077T3 DK93912267T DK93912267T DK0640077T3 DK 0640077 T3 DK0640077 T3 DK 0640077T3 DK 93912267 T DK93912267 T DK 93912267T DK 93912267 T DK93912267 T DK 93912267T DK 0640077 T3 DK0640077 T3 DK 0640077T3
Authority
DK
Denmark
Prior art keywords
alkyl
hydrogen
substituted
independently
antimicrobial agents
Prior art date
Application number
DK93912267T
Other languages
Danish (da)
English (en)
Inventor
Steven Joseph Brickner
Michael Robert Barbachyn
Ronald B Gammill
Douglas K Hutchinson
Mahest V Patel
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of DK0640077T3 publication Critical patent/DK0640077T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK93912267T 1992-05-08 1993-04-21 Oxazolidiner indeholdende en substitueret diazingruppe samt deres anvendelse som antimikrobielle midler DK0640077T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88043292A 1992-05-08 1992-05-08
PCT/US1993/003570 WO1993023384A1 (en) 1992-05-08 1993-04-21 Oxazolidinones containing a substituted diazine moiety and their use as antimicrobials

Publications (1)

Publication Number Publication Date
DK0640077T3 true DK0640077T3 (da) 2002-10-14

Family

ID=25376270

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93912267T DK0640077T3 (da) 1992-05-08 1993-04-21 Oxazolidiner indeholdende en substitueret diazingruppe samt deres anvendelse som antimikrobielle midler

Country Status (26)

Country Link
US (2) US5547950A (fi)
EP (1) EP0640077B1 (fi)
JP (1) JP3255920B2 (fi)
KR (1) KR100281775B1 (fi)
CN (1) CN1044236C (fi)
AT (1) ATE219770T1 (fi)
AU (1) AU668733B2 (fi)
CA (1) CA2133079C (fi)
CZ (1) CZ281884B6 (fi)
DE (1) DE69332061T2 (fi)
DK (1) DK0640077T3 (fi)
ES (1) ES2180545T3 (fi)
FI (1) FI945246A0 (fi)
HU (2) HUT72296A (fi)
IL (1) IL105555A (fi)
LV (1) LV13075B (fi)
MX (1) MX9302665A (fi)
MY (1) MY117338A (fi)
NO (1) NO306112B1 (fi)
PL (2) PL174909B1 (fi)
PT (1) PT640077E (fi)
RU (1) RU2105003C1 (fi)
SK (1) SK283420B6 (fi)
TW (1) TW274549B (fi)
WO (1) WO1993023384A1 (fi)
ZA (1) ZA932855B (fi)

Families Citing this family (126)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
MY115155A (en) * 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
WO1995014684A1 (en) * 1993-11-22 1995-06-01 The Upjohn Company Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones
US5668286A (en) * 1994-03-15 1997-09-16 Pharmacia & Upjohn Company Oxazolidinone derivatives and pharmaceutical compositions containing them
JPH0873455A (ja) * 1994-03-15 1996-03-19 Upjohn Co:The オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
DE4425612A1 (de) * 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
CN1046520C (zh) * 1994-11-15 1999-11-17 法玛西雅厄普约翰美国公司 二环噁嗪及噻嗪噁唑烷酮抗菌剂
ATE205205T1 (de) * 1995-02-03 2001-09-15 Upjohn Co Durch hetero-aromatische ring substituierte phenyloxazolidinone als antimikrobielles mittel
AU702752B2 (en) * 1995-05-11 1999-03-04 Pharmacia & Upjohn Company Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones
KR100463772B1 (ko) * 1995-09-01 2005-11-09 파마시아 앤드 업존 캄파니 엘엘씨 4내지8원헤테로사이클릭환에탄소-탄소결합을갖는페닐옥사졸리디논
MX9703040A (es) * 1995-09-12 1997-07-31 Upjohn Co Antimicrobianos de feniloxazolidinona.
ATE257829T1 (de) * 1995-09-15 2004-01-15 Upjohn Co Aminoaryl oxazolidinone n-oxide
ZA968661B (en) * 1995-11-17 1998-04-14 Upjohn Co Oxazolidinone antibacterial agent with tricyclic substituents.
ZA969622B (en) * 1995-12-13 1998-05-15 Upjohn Co Oxazolidinone antibacterial agents having a six-membered heteroaromatic ring.
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
GB9702213D0 (en) 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
MY116093A (en) * 1996-02-26 2003-11-28 Upjohn Co Azolyl piperazinyl phenyl oxazolidinone antimicrobials
CZ200788A3 (cs) * 1996-04-11 2017-01-25 Pfizer Inc. Způsob přípravy 5-aminomethyl substituovaných oxazolidinonaminů
AT403803B (de) 1996-04-19 1998-05-25 Sanochemia Ltd Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
GB9609919D0 (en) 1996-05-11 1996-07-17 Zeneca Ltd Chemical compounds
GB9614238D0 (en) * 1996-07-06 1996-09-04 Zeneca Ltd Chemical compounds
GB9614236D0 (en) * 1996-07-06 1996-09-04 Zeneca Ltd Chemical compounds
KR100307211B1 (ko) * 1997-05-24 2001-11-30 손 경 식 옥사졸리디논유도체,이의제조방법및그를함유한항균제조성물
US6037354A (en) * 1997-06-18 2000-03-14 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
NZ502253A (en) * 1997-07-11 2001-06-29 Upjohn Co Thiadiazolyl and oxadiazolyl phenyl oxazolidinone derivatives which are antibacterial agents
GB9717804D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9717807D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
KR100467309B1 (ko) * 1997-09-04 2005-07-18 씨제이 주식회사 옥사졸리디논유도체및그의제조방법및항균제조성물
KR100463111B1 (ko) * 1997-10-30 2005-06-13 씨제이 주식회사 신규한옥사졸리디논유도체및제조방법및그를함유하는항균제조성물
NZ504372A (en) * 1997-11-07 2002-12-20 Upjohn Co Process to produce N-[3-fluoro-4(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinones
SK284577B6 (sk) * 1997-11-12 2005-07-01 Pharmacia & Upjohn Company Deriváty oxazolidinónu, ich použitie a farmaceutické kompozície
ATE299021T1 (de) * 1997-11-18 2005-07-15 Pharmacia & Upjohn Co Llc Verwendung von oxazolidinonderivaten zur behandlung von psoriasis
US6040306A (en) * 1997-11-18 2000-03-21 Pharmacia & Upjohn Company Method of treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
AU780197B2 (en) * 1997-11-18 2005-03-10 Pharmacia & Upjohn Company Method of treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
BR9815615A (pt) * 1997-11-18 2000-10-24 Upjohn Co Uso de uma oxazolidinona para tratar psorìase, artrite e para reduzir a toxicidade da quimioterapia de câncer
GB9725244D0 (en) 1997-11-29 1998-01-28 Zeneca Ltd Chemical compounds
US6562844B2 (en) 1998-01-23 2003-05-13 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
WO1999037630A1 (en) 1998-01-23 1999-07-29 Versicor, Inc. Oxazolidinone combinatorial libraries, compositions and methods of preparation
US7002020B1 (en) 1998-01-23 2006-02-21 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
CA2315735A1 (en) * 1998-02-13 1999-08-19 Michael R. Barbachyn Substituted aminophenyl isoxazoline derivatives useful as antimicrobials
CN1311787A (zh) 1998-06-05 2001-09-05 阿斯特拉曾尼卡有限公司 噁唑烷酮衍生物、其制备方法以及含有它们的药物组合物
GB9812019D0 (en) * 1998-06-05 1998-07-29 Zeneca Ltd Chemical compounds
AU754529B2 (en) * 1998-09-22 2002-11-21 Yamanouchi Pharmaceutical Co., Ltd. Cyanophenyl derivatives
CA2351062A1 (en) * 1998-11-27 2000-06-08 Pharmacia & Upjohn Company Oxazolidinone antibacterial agents having a thiocarbonyl functionality
WO2000045177A1 (en) 1999-01-27 2000-08-03 Pharmacia & Upjohn Company Assays for modulators of elongation factor p activity
KR100333493B1 (ko) * 1999-05-27 2002-04-25 박호군 이소옥사졸릴 카르보닐 옥사졸리디논 유도체 및 이의 제조방법
KR100333492B1 (ko) * 1999-05-27 2002-04-25 박호군 이소옥사졸릴 메틸렌 옥사졸리디논 유도체 및 이의 제조방법
MXPA02000985A (es) * 1999-07-28 2002-07-30 Upjohn Co Oxazolidinonas y su uso como antiinfecciosos.
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
AR027261A1 (es) * 2000-02-02 2003-03-19 Upjohn Co Linezolid forma cristalina ii
US6642238B2 (en) 2000-02-10 2003-11-04 Pharmacia And Upjohn Company Oxazolidinone thioamides with piperazine amide substituents
US6514529B2 (en) * 2000-03-22 2003-02-04 Pharmacia & Upjohn Company Oxazolidinone tablet formulation
MY127336A (en) 2000-03-22 2006-11-30 Upjohn Co Container for linezolid iv solution
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
CA2411859A1 (en) * 2000-06-05 2001-12-13 Jae-Gul Lee Novel oxazolidinone derivatives and a process for the preparation thereof
PT1301207E (pt) 2000-06-30 2005-11-30 Pharmacia & Upjohn Co Llc Composicoes para o tratamento de infeccoes bacterianas que contem um composto de oxazolidinona, sulbactam e ampicilina
PL363960A1 (en) * 2000-07-17 2004-11-29 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
WO2003008389A1 (en) * 2001-07-16 2003-01-30 Ranbaxy Laboratories Limited Oxazolidinone derivatives as potential antimicrobials
WO2002032857A1 (en) 2000-10-17 2002-04-25 Pharmacia & Upjohn Company Methods of producing oxazolidinone compounds
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
ES2186550B2 (es) * 2001-06-27 2003-11-16 Vita Lab Nuevos derivados de oxazolidinonas como antibacterianos.
US6956040B2 (en) 2001-07-16 2005-10-18 Ranbaxy Laboratories Limited Oxazolidinone piperazinyl derivatives as potential antimicrobials
US7125568B2 (en) 2001-08-23 2006-10-24 Sung Michael T Lipophilic drug compositions
EP1427711B1 (en) * 2001-09-11 2005-07-13 AstraZeneca AB Oxazolidinone and/or isoxazoline derivatives as antibacterial agents
EP1443930A1 (en) 2001-10-25 2004-08-11 AstraZeneca AB Isoxazoline derivatives useful as antimicrobials
ATE323087T1 (de) * 2001-10-25 2006-04-15 Aryl substituierte oxazolidinone mit antibacterieller activität
TW200302095A (en) * 2002-01-25 2003-08-01 Upjohn Co Oxazolidinone cotherapy
BR0307468A (pt) * 2002-02-05 2004-11-09 Upjohn Co Derivados tiadiazinona antimicrobianos úteis no tratamento de infecções bacterianas
AR038536A1 (es) * 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
US7141588B2 (en) * 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
RU2354372C2 (ru) * 2002-03-29 2009-05-10 Фармация Энд Апджон Компани Ллс Парентеральное, внутривенное и пероральное введение оксазолидинонов для лечения инфекционных поражений стопы при диабете
AU2003231920A1 (en) * 2002-04-01 2003-10-13 Cadila Healthcare Limited Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them
AU2003230076A1 (en) * 2002-05-15 2003-12-02 Ranbaxy Laboratories Limited Polymorphic forms of phenyl oxazolidinone derivatives
MXPA05001199A (es) * 2002-07-29 2005-05-16 Ranbaxy Lab Ltd Derivados de oxazolidinona como antimicrobianos.
US7094900B2 (en) * 2002-08-12 2006-08-22 Pharmacia & Upjohn Company Llc N-Aryl-2-oxazolidinones and their derivatives
US20070167414A1 (en) * 2002-08-22 2007-07-19 Orchid Chemicals & Pharmaceuticals Limited Novel antibacterial agents
WO2004018439A1 (en) * 2002-08-22 2004-03-04 Orchid Chemicals & Pharmaceuticals Ltd Novel antibacterial agents
WO2004026848A1 (en) 2002-09-20 2004-04-01 Lupin Limited Oxazolidinone derivatives, process for their preperation and their use as antimycobacterial agents
US6875784B2 (en) * 2002-10-09 2005-04-05 Pharmacia & Upjohn Company Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
US7105547B2 (en) 2002-10-10 2006-09-12 Pharmacia And Upjohn Company Antimicrobial 1-aryl dihydropyridone compounds
EP1565186B1 (en) * 2002-11-21 2006-11-02 Pharmacia & Upjohn Company LLC N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinone-5-carboxamide derivates and related compounds as antibacterial agents
AU2002357561A1 (en) * 2002-12-30 2004-07-22 Nanjing Chang'ao Pharmaceutical Science And Technology Limited Company Oxazolidine derivative, methods of preparation and uses
DE10300111A1 (de) 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
MXPA05007724A (es) * 2003-02-07 2005-09-30 Warner Lambert Co Agentes antibacterianos.
JP2006516989A (ja) * 2003-02-07 2006-07-13 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 抗菌剤として使用するための二環式環によりｎ−置換されたオキサゾリジノン誘導体
US20040204463A1 (en) * 2003-04-01 2004-10-14 Harris Christina Renee N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
AU2003215861A1 (en) * 2003-04-07 2004-11-01 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
WO2004113329A1 (en) * 2003-06-20 2004-12-29 Orchid Chemicals And Pharmaceuticals Ltd. Oxazole derivatives as antibacterial agents
EP1660488A1 (en) * 2003-08-25 2006-05-31 Warner-Lambert Company LLC Novel antimicrobial aryloxazolidinone compounds
US7687627B2 (en) * 2003-09-08 2010-03-30 Wockhardt Limited Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
US7304050B2 (en) * 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
WO2005051933A1 (en) * 2003-11-28 2005-06-09 Ranbaxy Laboratories Limited An improved process for the synthesis of 4-(4-benzyloxy-carbonylamino-2-fluorophenyl)-piperazine-1-carboxylic acid tert-butyl ester, a key intermediate for oxazolidinone antimicrobials and compounds prepared thereby
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
WO2005113520A1 (en) * 2004-05-20 2005-12-01 Pharmacia & Upjohn Company Llc Substituted 2,3,5-trifluorphenyl oxazolidinones for use as antibacterial agents
JP2007504173A (ja) * 2004-06-29 2007-03-01 テバ ファーマシューティカル インダストリーズ リミティド リネゾリドのｉｖ型結晶
US20090247545A1 (en) * 2004-10-11 2009-10-01 Mukund Keshao Gurjar Substituted oxazolidinone derivatives
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
US7291614B2 (en) * 2005-02-24 2007-11-06 Teva Pharmaceutical Industries Ltd. Processes for the preparation of linezolid intermediate
WO2006109156A1 (en) 2005-04-15 2006-10-19 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
ATE449773T1 (de) 2005-06-29 2009-12-15 Pharmacia & Upjohn Co Llc Homomorpholinoxazolidinone als antibakterielle mittel
DE102005045518A1 (de) 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
CA2823159C (en) 2005-10-04 2014-10-21 Bayer Intellectual Property Gmbh Polymorphic form of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide
WO2008010070A2 (en) * 2006-07-19 2008-01-24 Orchid Research Laboratories Limited Novel oxazolidinone derivatives
US7593630B2 (en) 2006-07-24 2009-09-22 Foxconn Technology Co., Ltd. Built-in multidriver device for a camera zoom lens
WO2008143649A2 (en) * 2006-12-04 2008-11-27 Dr. Reddy's Laboratories Limited Novel oxazolidinone compounds as antiinfective agents
DE102007018662A1 (de) 2007-04-20 2008-10-23 Bayer Healthcare Ag Oxazolidinone zur Behandlung und Prophylaxe von pulmonaler Hypertonie
DE102007028318A1 (de) 2007-06-20 2008-12-24 Bayer Healthcare Ag Oxazolidinone zur Behandlung und Prophylaxe von Sepsis
WO2009032294A2 (en) * 2007-09-06 2009-03-12 Teva Pharmaceutical Industries Ltd. Processes for the preparation of a linezolid intermediate, linezolid hydroxide
CN101965353B (zh) * 2008-03-26 2014-12-17 丹诺医药(苏州）有限公司 共价连接到取代苯基噁唑烷酮的双环硝基咪唑类
EP2138178A1 (en) 2008-06-28 2009-12-30 Bayer Schering Pharma Aktiengesellschaft Oxazolidninones for the treatment fo chronic obstructive pulmonary disease (COPD) and/or asthma
EP2140866A1 (en) 2008-07-04 2010-01-06 Bayer Schering Pharma Aktiengesellschaft Oxazolidinones for the treatment of inflammatory conditions of the gastrointestinal tract
CN106220621B (zh) 2008-10-10 2019-06-11 默沙东公司 制备噁唑烷酮类的方法及含有噁唑烷酮类的组合物
PL2364975T3 (pl) * 2008-10-27 2013-12-31 Mitsubishi Tanabe Pharma Corp Nowa pochodna amidu i jej zastosowanie jako lek
KR20110092309A (ko) * 2008-11-20 2011-08-17 파나세아 바이오테크 리미티드 신규 항균제
SG10201500207QA (en) 2009-02-03 2015-03-30 Merck Sharp & Dohme Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
US8580767B2 (en) 2009-05-28 2013-11-12 Trius Therapeutics, Inc. Oxazolidinone containing dimer compounds, compositions and methods to make and use
CN103360379B (zh) * 2012-03-31 2017-05-24 南京圣和药业股份有限公司 噁唑烷酮化合物
WO2017156519A1 (en) 2016-03-11 2017-09-14 The Board Of Trustees Of The University Of Illinois Small-molecules active against gram-negative bacteria
US11274106B2 (en) 2017-06-23 2022-03-15 The Board Of Trustees Of The University Of Illinois Topoisomerase inhibitors with antibacterial and anticancer activity
WO2020021468A1 (en) 2018-07-25 2020-01-30 Cadila Healthcare Limited Substituted oxazolidinones for the treatment of mammalian infections
CN110372624A (zh) * 2019-08-13 2019-10-25 北京海美桐医药科技有限公司 一种噁唑烷酮类化合物、其制备方法及应用
WO2021184339A1 (en) * 2020-03-20 2021-09-23 Merck Sharp & Dohme Corp. Oxazolidinone compound and methods of use thereof as an antibacterial agent
WO2024069378A1 (en) * 2022-09-26 2024-04-04 Zydus Lifesciences Limited Novel compounds for the treatment of mammalian infections

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE29934E (en) * 1969-03-18 1979-03-13 Delalande S. A. Derivatives of 5-carbamoyloxymethyl-3-substituted-2-oxazolidinones, process of preparation thereof and therapeutic application
DE2263211A1 (de) * 1972-12-23 1974-07-04 Boehringer Sohn Ingelheim Neue arylpiperazine und verfahren zu ihrer herstellung
US4921869A (en) * 1987-10-09 1990-05-01 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4801600A (en) * 1987-10-09 1989-01-31 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
CA1320730C (en) * 1987-10-16 1993-07-27 The Du Pont Merck Pharmaceutical Company Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
ES2059467T3 (es) * 1987-10-21 1994-11-16 Du Pont Merck Pharma Derivados de aminometil-oxooxazolidinil-etenilbenceno utiles como agentes antibacterianos.
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
ATE201870T1 (de) * 1988-09-15 2001-06-15 Upjohn Co 3-(stickstoff substituierte)phenyl-5-beta- amidomethyloxazoliden-2-one

Also Published As

Publication number Publication date
NO944237L (no) 1995-01-04
PL174850B1 (pl) 1998-09-30
RU94046011A (ru) 1996-10-10
CA2133079A1 (en) 1993-11-25
ATE219770T1 (de) 2002-07-15
EP0640077B1 (en) 2002-06-26
EP0640077A1 (en) 1995-03-01
AU668733B2 (en) 1996-05-16
ZA932855B (en) 1994-10-24
MY117338A (en) 2004-06-30
JP3255920B2 (ja) 2002-02-12
KR100281775B1 (ko) 2001-02-15
PL174909B1 (pl) 1998-10-30
HUT72296A (en) 1996-04-29
SK133794A3 (en) 1995-06-07
SK283420B6 (sk) 2003-07-01
IL105555A0 (en) 1993-08-18
CA2133079C (en) 2004-08-03
CN1044236C (zh) 1999-07-21
TW274549B (fi) 1996-04-21
AU4287793A (en) 1993-12-13
JPH07506829A (ja) 1995-07-27
PT640077E (pt) 2002-11-29
ES2180545T3 (es) 2003-02-16
NO944237D0 (no) 1994-11-07
CZ250594A3 (en) 1995-08-16
CZ281884B6 (cs) 1997-03-12
NO306112B1 (no) 1999-09-20
US5547950A (en) 1996-08-20
HU211832A9 (en) 1995-12-28
DE69332061T2 (de) 2002-11-07
FI945246A (fi) 1994-11-08
FI945246A0 (fi) 1994-11-08
DE69332061D1 (de) 2002-08-01
LV13075B (en) 2004-01-20
KR950701327A (ko) 1995-03-23
CN1079964A (zh) 1993-12-29
WO1993023384A1 (en) 1993-11-25
RU2105003C1 (ru) 1998-02-20
US5700799A (en) 1997-12-23
MX9302665A (es) 1993-11-01
IL105555A (en) 1998-07-15

Similar Documents

Publication Publication Date Title
DK0640077T3 (da) Oxazolidiner indeholdende en substitueret diazingruppe samt deres anvendelse som antimikrobielle midler
IL110802A (en) Substituted oxazine and thiazine oxazolidinone antimicrobials and pharmaceutical compositions comprising them
BR9509673A (pt) Compostos e uso dos mesmos
BR9509136A (pt) Composto e uso do mesmo
ES8201560A1 (es) Un procedimiento para la preparacion de derivados de oxazo- lidona- o tiazolidona.
MX9703040A (es) Antimicrobianos de feniloxazolidinona.
TH14142EX (th) สารฆ่าเชื้อจุลินทรีย์ประเภทออกซะโซลิดินิโนนที่มีส่วนที่เป็นหมู่ไดแอซีนซึ่งถูกแทนที่
TH14142A (th) สารฆ่าเชื้อจุลินทรีย์ประเภทออกซะโซลิดินิโนนที่มีส่วนที่เป็นหมู่ไดแอซีนซึ่งถูกแทนที่